IT IS now widely accepted that the investigation of cytokine expression during inflammation can provide information about the pathogenesis of disease and help to define key therapeutic targets [1]. These studies have been greatly facilitated by the availability of recombinant human cytokines, essential for the development of specific assays. As assays have become more widely available, rheumato...